Amneal Pharmaceuticals, Inc. (AMRX) stock
AMRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/3063% above fair value
$21.12−0.11 (-0.52%)
Close on Nov 17, 2026Market cap $6.74BP/E 43.1Yield –
Amneal Pharmaceuticals pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Amneal Pharmaceuticals's pe ratio was 44.3× on Nov 11, 2026, against 626.0× a year earlier. Over the last 3 years it ranged from 8.8× to 956.0×, with a median of 56.5×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 44.3× | −585.7 |
| 2025 | Dec 31, 2025 | 630.0× | +540.8 |
| 2024 | Jan 31, 2024 | 89.2× | −12.0 |
| 2023 | Dec 29, 2023 | 101.2× | −75.8 |
| 2022 | Jul 29, 2022 | 177.0× | +123.8 |
| 2021 | Dec 31, 2021 | 53.2× | +42.1 |
| 2020 | Dec 31, 2020 | 11.1× | – |
See a number that looks wrong?